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ABSTRACT 
There are common pathways by which psychological stress and exercise stress alter 
immunity. However, it remains unknown whether psychological stress plays a role in the in 
vivo immune response to exercise. We examined the relationship between anxiety and 
perceived psychological stress reported before exercise and in vivo immunity after exercise 
using skin sensitisation with Diphenylcyclopropenone (DPCP).  In a randomised design, sixty 
four, thoroughly familiarised, males completed widely used psychological instruments to 
assess state-anxiety and perceived psychological stress before exercise, and ran either 30 
minutes at 60% (30MI) or 80% (30HI) V̇O2peak, 120 minutes at 60% (120MI) V̇O2peak or 
rested (CON) before DPCP sensitisation. Cutaneous recall to DPCP was measured as the 
dermal thickening response to a low-dose series DPCP challenge 4-weeks after sensitisation. 
After accounting for exercise (R
2 
= 0.20; P < 0.01), multiple-regression showed that pre-
exercise state-anxiety (STAI-S; ΔR2 = 0.19; P < 0.01) and perceived psychological stress 
(ΔR2 = 0.13; P < 0.05) were moderately associated with the DPCP response after exercise. 
The STAI-S scores before exercise were considered low-to-moderate in these familiarised 
individuals (median split; mean STAI-S of low 25 and moderate 34). Further examination 
showed that the DPCP response after exercise (30MI, 30HI or 120MI) was 62% lower in 
those reporting low vs. moderate state-anxiety before exercise (mean difference in dermal 
thickening: -2.6 mm; 95% CI: -0.8 to -4.4 mm; P < 0.01). As such, the results indicate a 
beneficial effect of moderate (vs. low) state-anxiety and perceived psychological stress on in 
vivo immunity after exercise. Moreover, correlations were of comparable strength for the 
relationship between physiological stress (heart rate training impulse) and the summed 
dermal response to DPCP (r = -0.37; 95% CI: -0.05 to -0.62; P = 0.01), and state-anxiety and 
the summed dermal response to DPCP (r = 0.39; 95% CI: 0.08 to 0.63; P < 0.01). In 
conclusion, state-anxiety and perceived psychological stress levels before exercise play an 
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important role in determining the strength of the in vivo immune response after exercise. 
These findings indicate a similar strength relationship for the level of state-anxiety prior to 
exercise and the level of physiological stress during exercise with the in vivo immune 
response after exercise. Future research is required to investigate exercise-immune responses 
in athletes, military personnel and others in physically demanding occupations experiencing 
higher levels of psychological stress than those reported in this study e.g. related to important 
competition, military operations and major life events. Nevertheless, the present findings 
support the recommendation that exercise scientists should account for anxiety and 
psychological stress when examining the immune response to exercise. 
KEYWORDS: Running, Immunity, In vivo, Diphencyprone, STAI 
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INTRODUCTION 
Numerous studies report an increase in upper respiratory tract infection (URTI) symptoms 
following a bout of strenuous exercise and during periods of heavy training in athletes (25, 
33, 37), and there is widespread agreement that a transient suppression of immune function is 
at least partly responsible (48). A multitude of training and lifestyle stressors are thought to 
be involved in the observed decrease in immune function in athletes and military personnel; 
including, prolonged training sessions, exposure to environmental extremes (e.g. heat, cold 
and high altitude), poor nutrition and poor sleep (41-43, 47, 48). For example, prolonged 
heavy exercise (≥ 2 h) transiently decreases in vitro measures of immunity in isolated blood 
samples (48) and more clinically meaningful in vivo measures of immunity instigated at the 
skin, including delayed type hypersensitivity (DTH) and contact hypersensitivity (CHS) (6, 
16, 24). Indeed, recent work highlights the immunosuppressive effect of prolonged exercise 
(2 h) on the induction of CHS using the novel antigen Diphenylcyclopropenone (DPCP) (16, 
24). Besides the immunosuppressive effects of prolonged heavy training sessions, the training 
environment and lifestyle stressors such as nutritional deficits (e.g. energy, macro- and 
micro- nutrients) and poor sleep (e.g. total deprivation and disruption) have long been 
implicated in the decrease in immune function in athletes and military personnel (41-43). 
Somewhat surprisingly, field studies (multi-stressor environment) and laboratory studies 
mimicking real-world athletic and military scenarios by exposing participants to these 
stressors, either separately or combined, demonstrate only subtle and short-lived modulation 
of immunity at rest and in response to exercise (5, 28, 31, 40). Rather than decrease 
immunity, some studies actually show a beneficial ‘priming’ effect of stressors such as short-
term sleep disruption (1 night) (28), intermittent cold exposure (29) and intermittent hypoxic 
exposure on immunity (50). As such, there is a pressing need for research investigating other 
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likely behavioural, environmental and lifestyle candidates involved in the observed decrease 
in immune function in athletes and military personnel. 
 
Given the well-known and marked influence of psychological stress on immunity and 
infection resistance (10, 13), and the likely shared mechanisms by which psychological stress 
and exercise stress alter immunity (36); i.e. principally through activation of the 
hypothalamic-pituitary-adrenal (HPA) axis and sympathetic-adrenal-medullary (SAM) axis 
and subsequent immunomodulatory hormones, it has been hypothesised that psychological 
stress can play a role in the decrease in immunity with prolonged heavy exercise and heavy 
training (8, 36, 49). Unfortunately, exercise immunologists rarely report measures of 
psychological stress in their studies and so there is little by way of empirical evidence to 
support this hypothesis (38). That there are striking similarities in the way acute and chronic 
psychological stress and acute and chronic exercise stress influence immunity provides 
indirect support for this hypothesis. For example, although chronic psychological stress is 
widely accepted to decrease immunity and increase infection risk (10, 13), short-lasting, 
moderate-intensity psychological stress can enhance in vivo immunity (21) and is considered 
a fundamental adaptive response to help us survive (13). Similarly, prolonged heavy exercise 
and heavy training are widely accepted to decrease immunity and increase infection risk (48), 
but short-lasting, moderate-intensity exercise stress can enhance in vivo immunity (34). 
 
With this information in mind, using a multiple linear regression model, we tested, and 
provide evidence supporting our hypothesis that the level of anxiety and perceived 
psychological stress reported by an individual prior to exercise play an important role in 
determining the strength of the in vivo immune response to DPCP after exercise. 
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METHODS 
Using the CHS responses to exercise from a previous study (16), here we present previously 
unpublished and novel insights regarding the influence of anxiety and perceived 
psychological stress on in vivo immunity after exercise.  
 
Participants  
Sixty four healthy, non-smoking, recreationally active males (age 22 ± 3 years; height 180 ± 
6 cm; body mass 76.7 ± 11.5 kg; V̇O2peak 57 ± 6 mL/kg/min) gave written informed consent 
to participate in the study. Participants had no previous history of exposure to DPCP and 
were excluded if they were taking any medication or dietary supplements, or had a history of 
atopy or any other immune-related or inflammatory dermatological condition. Participants 
were required to abstain from alcohol and exercise for 24 h before and 48 h after the 
experimental trials. The study received local ethics committee approval, and all protocols 
were conducted in accordance with the Declaration of Helsinki (2013). 
 
Participants were matched for age and aerobic fitness (gas exchange threshold and V̇O2peak) 
before being randomly assigned to one of four groups. Groups were 1) 120 min of seated rest 
(CON); 2) 30 min of moderate-intensity (60% V̇O2peak) exercise (30MI); 3) 30 min of high-
intensity (80% V̇O2peak) exercise (30HI); or 4) 120 min of moderate-intensity (60% V̇O2peak) 
exercise (120MI).  
 
Preliminary measures and familiarisation  
V̇O2peak was estimated by means of a ramped exercise test on a treadmill (h/p/cosmos 
Mercury 4.0, Nussdorf-Traunstein, Germany) as described (16). At least 24 h after the 
preliminary measures and approximately 7 days before the experimental trial, participants 
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were informed of their group allocation and attended the laboratory for familiarisation. For 
exercising participants, the calculated exercise intensity was verified, and the participant was 
familiarised by running for 50% of their allocated exercise duration. During this visit, all 
participants were familiarised with blood sampling and other relevant procedures. 
 
Experimental procedures  
On the day of the experimental trial, participants were transported to the laboratory at 0730 h 
and provided with a standard breakfast (0.03 MJ/kg) before completing widely used, 
validated psychological instruments. The level of anxiety was assessed using the state aspect 
of the State Trait Anxiety Inventory (STAI-S): the STAI-S is one of the most commonly used 
scales to measure anxiety, which has been defined as an unpleasant emotional state that exists 
at a given moment in time and at a particular level of intensity, and is characterised by 
subjective feelings of tension, apprehension, nervousness, and worry (45). The STAI-S 
consists of 20-items, with responses being measured on a four-point Likert scale (from 1 ‘not 
at all’ to 4 ‘very much so’) and a range of scores from 20−80 (composite reliability = 0.94). 
Perceived psychological stress was assessed using the Perceived Stress Scale (PSS): the PSS 
is a widely used psychological instrument for measuring the perception of stress, and 
measures the degree to which life situations are considered stressful by the individual during 
the previous month (11). The PSS is a 14-item inventory, with responses measured on a five-
point Likert scale (from 0 ‘never’ to 4 ‘very often’) and a range of scores from 0−56 
(composite reliability = 0.73). Average PSS score for young adults has been reported as 21 ± 
7 and high PSS score in posttraumatic stress disorder patients as 34 ± 8 (11, 26). Participants 
assigned to 120MI began running on a treadmill at 1100 h, and those assigned to 30HI and 
30MI began at 1230 h, so that all participants completed the exercise at the same time of day 
(1300 h). Heart rate was monitored continuously during the experimental trials (Polar FT1, 
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Polar Electro, Kempele, Finland). Immediately after the exercise, participants showered and 
returned to the laboratory within 15 min of completion before being sensitised to DPCP at 
1320 h, exactly 20 min after exercise cessation. This short standardised delay in sensitisation 
allowed cutaneous blood flow to return to baseline (16). 
 
Blood collection and analysis  
Blood samples were collected before, immediately after, and 1 h after exercise or seated rest 
by venepuncture into two separate vacutainer tubes (Becton Dickinson, Oxford, UK), one 
containing K3EDTA, and one containing lithium heparin. The samples were spun at 1500 g 
for 10 minutes in a refrigerated centrifuge. Plasma was aliquoted into Eppendorf tubes, and 
immediately frozen at -80 C for later analysis. Plasma epinephrine and norepinephrine were 
determined on K3EDTA plasma, and plasma cortisol was determined on lithium heparin 
plasma using commercially available ELISA kits (CatCombi, IBL International, Hamburg, 
Germany and DRG Instruments, Marburg, Germany, respectively). The intra-assay 
coefficient of variation for plasma epinephrine, norepinephrine and cortisol was 4.1%, 4.1% 
and 4.4%, respectively.  
 
Induction of CHS  
The sensitising exposure to the novel antigen DPCP involved application of an occluded 
patch, constituting a 12-mm aluminium Finn chamber (Epitest Oy, Tuusula, Finland) on 
scanpor hypoallergenic tape containing an 11-mm filter paper disc (16). The paper disc was 
soaked in 22.8 μL of 0.125% DPCP in acetone (patch = 30 μg/cm2 DPCP) and allowed to dry 
for 5 min before being applied to the skin on the lower back for exactly 48 h. 
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Elicitation  
The magnitude of in vivo immune responsiveness was quantified by measuring the responses 
elicited by secondary exposure to DPCP. Twenty eight days after the initial sensitisation to 
DPCP, all participants received a challenge with a low-concentration dose-series of DPCP on 
individual patches, each comprising an 8-mm aluminium Finn chamber on scanpor 
hypoallergenic tape containing a 7-mm filter paper disc. Patches were applied to the volar 
aspect of the upper arm in the following concentrations: 10 μL of DPCP: 0.0048%, 1.24 
μg/cm2; 0.0076%, 1.98 μg/cm2; 0.0122%, 3.17 μg/cm2; 0.0195%, 5.08 μg/cm2; 0.0313%, 
8.12 μg/cm2; and, 10 μL of 100% acetone served as a control patch for background 
subtraction. Patches were applied in randomly allocated order at the local site to minimise 
any anatomical variability in responses. Elicitation patches were removed after 6 h, and the 
strength of immune reactivity was assessed as the cutaneous responses 48 h after application 
(16). 
 
Assessment of CHS responses  
Dermal thickness was determined at each elicitation site using a high-frequency ultrasound 
scanner (Episcan, Longport Inc, Reading, UK). The ultrasound probe was placed over the 
centre of each patch site together with ultrasound gel. The mean of three measurements was 
taken from each 12-mm scan image assessed at a later time by a blinded investigator. Mean 
skinfold thickness was determined from triplicate measurements at each elicitation site using 
modified spring-loaded skin callipers (Harpenden Skinfold Calliper, British Indicators, 
England, UK).  As previously described (24), this method provides an objective measure of 
skin oedema (inflammatory swelling). Skinfold thickness was recorded to the nearest 0.1 mm 
by placing the jaws of the calliper at the outer diameter of the response site and measuring 
skin thickness only (no subcutaneous fat). Skinfold thickness assessed using skinfold 
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callipers has previously been shown to be strongly related (r = 0.93) with high-frequency 
ultrasound readings of dermal thickness (16). Mean skin erythema was determined from 
triplicate measurements at each elicitation site using an erythema meter (ColorMeter DSM11, 
Cortex Technology, Hadsund, Denmark) which provides an objective measure of skin 
redness (24). Mean background values were determined from triplicate measurements at the 
acetone patch site for both thickness and redness. To determine the increase in thickness and 
redness, the value from the acetone-only site was subtracted from each elicitation site value. 
The values for increase in dermal thickness, skinfold thickness and erythema over all the 
doses were summed to give an approximation of the area under the dose–response curve, 
representative of the overall reactivity of each participant to DPCP (24). 
 
Statistical analyses  
Hierarchical linear regression analysis was used to examine the relationship between STAI-S 
and PSS (in 2 separate models) and in vivo immunity after exercise. In step 1 of each model, 
the influence of exercise on the summed dermal thickening response to DPCP was accounted 
for by calculating the training impulse (TRIMP) to reflect the level of physiological stress, as 
described (2). In step 2, the influence of each psychological measure on the summed dermal 
thickening response to DPCP was assessed. Sample size was deemed appropriate for the 
multiple linear regression analysis with 2 steps, in line with recommendations (46). To 
further illustrate the influence of anxiety on in vivo immunity after exercise, we performed 
additional analyses by categorising the population based on STAI-S scores using a median 
split; whereby, the levels before exercise were defined as low anxiety (LOW: STAI-S ≤ 29; 
mean 25) and moderate anxiety (MOD: STAI-S ≥ 30; mean 34): the STAI-S ranges for LOW 
and MOD are in line with those reported in the literature (30, 45). Independent t-tests were 
used to compare the summed dermal responses to DPCP in LOW and MOD in each group 
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(30MI, 30HI, 120MI and CON). Comparisons of psychological measures between groups 
(30MI, 30HI, 120MI and CON) were made using one-way ANOVA. A two-way, mixed-
model ANOVA was used to analyse DPCP responses across the full dose-series challenge 
(anxiety level x dose) and circulating stress hormones (anxiety level x time) with significant 
differences identified using post hoc Tukey HSD, where appropriate. Pearson correlation 
coefficients were also calculated between physiological stress (TRIMP) and the DPCP 
response, and anxiety and the DPCP response. To determine the influence of anxiety on the 
threshold DPCP dose that elicits a response, logarithmic transformation was performed on the 
DPCP data (LOW vs. MOD). This enabled the calculation of the x-intercept when y = 0, 
using linear regression on the linear portion of the dose-response curve. A threshold dose for 
a response to DPCP was then calculated by back transformation (antilog). Data are presented 
as mean ± SD, unless otherwise stated and statistical significance was accepted at P < 0.05. 
Data were checked for normality and where appropriate natural log transformation was 
performed before analysis. Statistical analyses were performed using common statistical 
software packages (SPSS 22; IBM, Chicago, IL, and GraphPad Prism 5.0, San Diego, CA). 
Cohen’s d effect sizes (d) are presented to indicate the meaningfulness of group differences 
for DPCP responses; whereby, values greater than 0.2, 0.5, and 0.8 represent small, medium, 
and large effects, respectively (9). 
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RESULTS 
STAI-S Anxiety 
Prior to exercise, there were no differences in psychological measures between groups (e.g. 
STAI-S scores for 30MI, 30HI, 120MI and CON) and participants reported low-to-moderate 
STAI-S scores (Fig. 1A). In step 1 of the regression model (Table 1), exercise (TRIMP; 78 ± 
60 AU) was a significant predictor accounting for 20% of the variance in the summed dermal 
thickening response to DPCP (P < 0.01); whereby, greater physiological stress was 
associated with a lower DPCP response following exercise. In step 2, STAI-S score was a 
significant predictor over and above exercise, accounting for an additional 19% of the 
variance in DPCP response (P < 0.01); together, exercise and anxiety accounted for 39% of 
the variance in the dermal thickening response to DPCP (Table 1). Pearson correlation 
coefficients were of comparable, moderate strength for the relationship between 
physiological stress and the summed dermal response to DPCP (TRIMP; r = -0.37, R
2
 = 0.13, 
P = 0.01), and anxiety and the summed dermal response to DPCP (STAI-S score; r = 0.39, R
2
 
= 0.15, P < 0.01). This association between anxiety before exercise and in vivo immunity 
after an exercise challenge indicates that LOW were more likely to have a lower DPCP 
response following exercise stress than MOD (Fig. 1B). When reported as the summed 
response to the five DPCP challenge doses, dermal thickening response was 62% lower in 
LOW than MOD (LOW 1.6 ± 2.3 and MOD 4.2 ± 3.1 mm; P < 0.01; d = 1.0).  
 
***Table 1 near here*** 
***Fig. 1 near here*** 
 
The ubiquitous influence of anxiety on in vivo immunity after exercise challenge (but not 
rested CON) is further illustrated in the comparisons between LOW and MOD in each group 
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(30MI, 30HI, 120MI and CON; Fig. 2A-D). Responses to DPCP assessed as skinfold 
thickness and erythema (data not shown for brevity), were smaller in LOW vs. MOD for 
30MI (P < 0.01) and 30HI (P < 0.05; Fig. 2A-B), but not CON. The suppressive effect of 
LOW vs. MOD was also apparent in 120MI (P = 0.05; d = 0.9; Fig. 2C) which is particularly 
striking given that the suppressive effect of prolonged exercise on the induction of DPCP 
immune memory has been reported (16). The lower CHS response to exercise in LOW vs. 
MOD is also illustrated in the smaller dermal thickening response across the full dose-series 
of DPCP in LOW vs. MOD (F(1, 35) = 11.1, P < 0.01; Fig. 1B for 30MI and 30HI). 
Furthermore, the threshold dose for a positive response to DPCP was calculated using the 
linear part of the dose-response curves. Compared with MOD, LOW required a 4-times 
greater DPCP dose (1.5 μg/cm2) to elicit a positive response.  
 
***Fig. 2 near here*** 
 
Perceived Stress Scale 
Participants reported low-to-moderate PSS scores (16.5 ± 5.3). After accounting for the 
influence of exercise in step 1 of the regression model (Table 1), PSS score was a significant, 
moderate predictor (in step 2), accounting for an additional 13% of the variance in DPCP 
response (P < 0.05); together, exercise and PSS score accounted for 33% of the variance in 
the dermal thickening response to DPCP (Table 1). This association between the perception 
of psychological stress in the last month (i.e. the degree to which life situations are 
considered stressful) and in vivo immunity after exercise challenge indicates that participants 
reporting lower life stress were more likely to have a lower DPCP response following an 
exercise challenge than participants reporting moderate life stress. 
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Circulating stress hormones 
When comparing LOW and MOD, a significant anxiety level x time interaction was observed 
for circulating epinephrine concentration (F(2, 88) = 5.9; P < 0.01); whereby, epinephrine 
was lower in LOW than MOD at pre-exercise (LOW 0.25 ± 0.17 vs. MOD 0.58 ± 0.46 
nmol/L; P < 0.01), but not different at post or 1 h post-exercise. Similarly, an independent t-
test showed that circulating cortisol concentration was also lower pre-exercise in LOW than 
MOD (LOW 545 ± 190 vs. MOD 699 ± 289 nmol/L; P < 0.05); albeit, there was no 
significant interaction. Nevertheless, the lower circulating epinephrine and cortisol 
concentration in LOW than MOD before exercise represent large (d = 0.94) and medium (d = 
0.63) effects, respectively. Circulating norepinephrine was not different between LOW and 
MOD. 
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DISCUSSION 
The aim of this work was to investigate the influence of anxiety and perceived psychological 
stress on the in vivo immune response after exercise. The findings support our hypothesis that 
the level of anxiety and perceived psychological stress reported by the individual prior to 
exercise play an important role in determining the strength of the subsequent in vivo immune 
response after exercise (Table 1 and Fig. 1): in vivo immunity was assessed by DPCP 
sensitisation after exercise and recall responses measured 28 d later. Moreover, the findings 
indicate a similar, moderate strength relationship for the level of anxiety prior to exercise 
(STAI-S; r = 0.39) and the level of physiological stress during exercise (TRIMP; r = -0.37) 
with the in vivo immune response after exercise challenge. The ubiquitous influence of 
anxiety on the immune response after exercise is further evidenced by a lower in vivo 
immune response to DPCP in individuals reporting low compared with moderate anxiety, 
regardless of the intensity and duration of the exercise challenge (30MI, 30HI and 120MI, 
Fig. 2A−C). These findings support the recommendation that exercise scientists should 
account for anxiety and psychological stress when examining the immune response to 
exercise. 
 
The findings of the present study demonstrate an important interaction between the a priori 
level of anxiety and perceived psychological stress and the subsequent immune response after 
an exercise challenge. We previously showed no significant influence of 30MI or 30HI on in 
vivo immunity (16), but these new insights show a lower in vivo immune response in 
individuals reporting low compared with moderate anxiety in 30MI and 30HI (Fig. 2A−B). 
Moreover, although we have previously shown a suppressive effect of 120MI compared with 
rested control on in vivo immunity (16), particularly striking is the 50% lower in vivo immune 
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response in individuals reporting low compared with moderate anxiety on 120MI (Fig. 2C). 
Given that DPCP is benign, determining the clinical significance of these findings, with 
specific regard to infection (skin and other) is an important avenue for future research. 
Preferably, the strength of the cutaneous recall response to DPCP could be generalised 
beyond skin immunity to indicate the immune system’s general ability to respond to an 
infectious challenge. The available evidence in this regard is supportive as cutaneous immune 
measures are impaired in individuals with acute infectious illness (3, 22), diabetes and 
psoriasis (1) and predict mortality in critically ill HIV-infected patients (17). That we show 
lower pre-exercise circulating cortisol and epinephrine in the low compared with moderate 
anxiety group raises the possibility that stress hormones may modulate the immune response 
to subsequent exercise; indeed, stress hormones are considered to play important roles in 
preparing the immune system for challenge (13, 15). For example, administration of 
physiological doses of corticosterone and epinephrine increased T-cell drainage away from 
the site of DTH challenge to lymph nodes, which in-turn enhanced the DTH response in rats 
(15). In addition, adrenalectomy has been shown to eliminate stress-induced immune-
enhancement in rats, likely by reducing the glucocorticoid and epinephrine response (15). 
Nevertheless, post-exercise circulating cortisol and epinephrine were not different between 
individuals reporting low and moderate anxiety in the present study; as such, further research 
is required into the underlying mechanisms.  
 
Regarding the timing of the psychological measurements, the findings were unlikely due to 
an acute anticipatory effect prior to exercise as our participants underwent thorough 
familiarisation to all procedures, including running 50% of their allocated exercise duration; 
indeed, the success of familiarisation is shown as similar STAI-S scores prior to exercise and 
rested CON (Fig. 1A). In addition, our findings for the relationship between STAI-S score 
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and the in vivo immune response after exercise are further supported by the relationship 
between PSS score and the in vivo immune response after exercise: PSS assesses the 
perception of stress, and measures the degree to which life situations spanning the last month 
are considered stressful (whereas STAI-S provides an acute measure of anxiety) (11). As 
such, the PSS findings provide added confidence regarding the observed association between 
psychological stress and the in vivo immune response after exercise challenge. It remains to 
be shown whether individuals are predisposed to respond to stressful situations, such as 
competitive sport or military scenarios, in a predictable manner with regards to neuro-
endocrine-immune responses. In support of this notion, there is some evidence that 
personality traits predict endocrine-stress-reactivity (4, 19); nevertheless, further research is 
required to investigate this novel concept in exercise immunology, and to establish whether 
the findings of the present study extend to other immune measures e.g. vaccination responses 
(7) and mucosal immunity (23). Further research is also required to disentangle the influence 
of psychological and physiological strain during prolonged exercise (e.g. during endurance 
and ultra-endurance events) on in vivo immunity. Psychological stress measurements were 
made before exercise in the present study and it is reasonable to assume that psychological 
stress during more prolonged exercise (e.g. 120MI) might also play a role in the observed 
decrease in the in vivo immune response (Fig. 2C). 
 
Bridging the gap between exercise immunology and psycho-neuro-immunology 
Research investigators have long since acknowledged a role for psychological stress in the 
decrease in immunity associated with heavy exercise and training but there is little empirical 
research to support this hypothesis (8, 36). Since Clow and Hucklebridge’s Exercise 
Immunology Review article highlighting this working hypothesis in 2001 (8) there have been 
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> 3,000 peer-reviewed publications in exercise immunology (using the search terms 
‘exercise’ and ‘immune’, Web of ScienceTM) yet < 5% of these publications include the 
search terms ‘psychological stress’ or ‘anxiety’. Closer inspection of this small subset of 
exercise immunology publications reveals that the large majority mention a putative role for 
psychological stress or anxiety in exercise-immune modulation; however, only a small 
handful of original investigations either attempt to manipulate psychological stress or include 
objective measures of psychological stress (27, 32, 38, 39). The present study answers the 
recent calls to physiologists (51) and exercise immunologists (49) to incorporate objective 
psychological measurements in their human studies.  
 
The findings herein support the recommendation that exercise immunologists should include 
aspects of mental health (e.g. psychological stress and others), in a broader conceptual 
framework of exercise-immune interactions alongside other factors thought to decrease 
immunity in athletes and military personnel (e.g. prolonged training sessions, poor nutrition 
etc.). This will inform and direct research questions and experimental designs with the aim of 
improving our understanding of the complicated exercise-immune interactions and with the 
potential to provide effective countermeasures to immune impairment in those concerned. To 
this end, the exercise immunologist’s toolkit will be enhanced by joining forces with experts 
in the ever expanding field of psycho-neuro-immunology to begin to disentangle the 
psychosocial and physiological underpinning of decreased immunity and increased infection 
risk in high level athletes, military personnel and others in physically demanding occupations. 
Our finding that pre-exercise anxiety and perceived psychological stress accounted for 
additional variance in post-exercise in vivo immunity after accounting for exercise (using 
TRIMP) emphasises the importance of incorporating psychological measurements in studies 
investigating the immune response to exercise. As do the similar strength correlations for pre-
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exercise anxiety (STAI-S; r = 0.39) and physiological stress during exercise (TRIMP; r = -
0.37) with in vivo immunity after exercise. These findings indicate a beneficial effect of 
moderate (vs. low) anxiety and perceived psychological stress on in vivo immunity after 
exercise (Fig. 2A and D); as such, the findings accord with the immune-enhancement theory 
of moderate stress (13, 20, 21). Further research is required to investigate exercise-immune 
responses in athletes, military personnel and others in physically demanding occupations (e.g. 
firefighters and mountain rescue workers) experiencing higher levels of psychological stress 
than those reported in this study e.g. as might occur in relation to important competition, 
major life events etc. The immuno-suppressive effects of chronic high stress in rats (3 weeks 
of restraint and shaking stress) (14) and humans (examination period) (44) are widely 
acknowledged (13). As such, research is required to test the hypothesis that chronic high 
levels of psychological stress exacerbate the decrease in in vivo immunity after exercise. 
Irrespective, the present findings support the recommendation that exercise scientists should 
account for anxiety and psychological stress when examining the immune response to 
exercise, and for coaches and support staff to monitor anxiety and psychological stress 
alongside more traditional physiological measures of training stress. Accordingly, recent 
evidence highlights that aspects of mental health such as psychological stress and depression 
are important risk factors for illness in Olympic athletes (18). In time, studies may 
demonstrate the utility of interventions to alter psychological stress in order to optimise 
immunity and host defence in athletes, military personnel and those in physically demanding 
occupations. There is good reason for optimism as an 8-week mindfulness meditation 
programme increased the antibody response to influenza vaccine in employees working in a 
highly stressful environment (vs. waiting-list controls) (12). Also, although somewhat limited 
methodologically, preliminary work in competitive athletes showed that a 3-week stress 
management intervention reduced the number of days out due to illness and injury (35). 
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CONCLUSIONS 
In conclusion, these findings show that anxiety and perceived psychological stress levels 
prior to exercise play an important role in determining the strength of the in vivo immune 
response after exercise. Moreover, these findings indicate a similar, moderate strength 
relationship for the level of state-anxiety prior to exercise and the level of physiological stress 
during exercise with the in vivo immune response after exercise. Future research is required 
to investigate exercise-immune responses in athletes and others in physically demanding 
occupations experiencing higher levels of psychological stress than those reported in this 
study e.g. related to important competition and major life events. Nevertheless, these findings 
support the recommendation that exercise scientists should account for anxiety and 
psychological stress when examining the immune response to exercise. 
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FIGURE LEGENDS 
FIGURE 1. Effect of state-anxiety prior to exercise on the in vivo immune response after 
exercise. (A) Low (LOW) and moderate (MOD) levels of anxiety. Data are Mean ± SD. (B) 
Contact hypersensitivity (CHS) assessed as elicitation challenge 28 d after DPCP induction. 
Dermal thickening response to the full dose-series challenge with DPCP is shown (30MI and 
30HI). Data are Mean ± SEM for clarity. 
1
Shown for comparison. 
 
FIGURE 2. Effect of state-anxiety prior to exercise on the in vivo immune response after 
exercise of varying intensity and duration. (A−D) Summed increase in skinfold thickening 
response to DPCP challenge for each exercise group (30MI, 30HI and 120MI) and rested 
CON. Data are Mean ± SD.  
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TABLE 1. Multiple linear regression analysis examining the influence of state-anxiety and 
perceived psychological stress level prior to exercise on the subsequent in vivo immune 
response after exercise. Contact hypersensitivity (CHS) assessed as the summed dermal 
thickening response to the full dose-series elicitation challenge with DPCP 28 d after DPCP 
induction. After accounting for the negative influence of exercise in step 1, separate models 
show the positive influence of anxiety (from low to moderate levels), assessed using STAI-S 
in step 2 (A) and perceived psychological stress (from low to moderate levels) over the last 
month, assessed using PSS in step 2 (B), respectively. 
 
Dependent variable: CHS B SE β t ΔF R2 ΔR2 
A. Step 1         
Exercise (TRIMP)
1
 -0.005 0.002 -0.44 -2.93 8.56 0.20** 0.20** 
Step 2        
STAI-S 0.06 0.02 0.44 3.24 10.50 0.39** 0.19** 
        
B. Step 1  
Exercise (TRIMP)
1
 
 
-0.005 
 
0.002 
 
-0.44 
 
-2.93 
 
8.56 
 
0.20** 
 
0.20** 
Step 2 
PSS 
 
0.06 
 
0.02 
 
0.36 
 
2.54 
 
6.45 
 
0.33** 
 
0.13* 
 
1
TRIMP = training impulse; STAI-S = State Trait Anxiety Inventory; PSS = Perceived Stress 
Scale;* P < 0.05; ** P < 0.01. 
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FIGURE 1. 
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FIGURE 2. 
 
 
